Log-In
|
Home
|
E-mail Alerts
|
My Headlines
|
Portfolio
Upgrade to StreetInsider Premium - FREE TRIAL!
Join Free
SI Premium
Full Feed View
Headline View
Upgrade to SI Premium
Ratings Insider
Analyst Comments
Hot Analyst Comments $
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Credit Ratings
Downgrade News
Hot Downgrades $
New Coverage News
Hot New Coverage $
Upgrade News
Hot Upgrades $
More...
M&A Insider
Merger News $
Hot M&A News $
Private Equity
Rumors $
Merger Arbitrage
2013's Top M&A Deals
Top 50 Takeover Targets
More...
EPS Insider
Earnings Calendar
Earnings News
Hot Earnings $
Guidance
Hot Guidance $
Conference Calls
Earnings History Search
More...
Dividend Insider
Dividend News
Special Dividends $
Stock Buybacks
Hot Stock Buybacks $
Stock Splits
More...
IPO Insider
IPO News
Recent IPOs
Upcoming IPOs
More...
Hedge Fund Insider
Hedge Funds News
More...
Partners
QUICK LINKS :
Upcoming Dividends
EPS Movers
Top Upgrades
Buffett's Stocks
*NEW SI App
Newsletters
Follow @Street_Insider
More on GALT
- Summary
- Chart
- Profile
- Historical
Data
- Earnings
- Ratings
News
- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...
- 13Ds
- 13Fs
- 13Gs
- Analyst Comments
- Analyst EPS Change
- Analyst EPS View
- Analyst PT Change
- Commodities
- Conference Calls
- Contributors
- Corporate News
- Credit Ratings
- Dividends
- Downgrades
- Earnings
- Economic Data
- Equity Offerings
- ETFs
- FDA
- Fed
- Forex
- General News
- Hedge Funds
- Hot Buybacks
- Hot Comments
- Hot Corp. News
- Hot Dividends
- Hot Downgrades
- Hot Earnings
- Hot FDA News
- Hot Guidance
- Hot Hedge Fund News
- Hot Insider Trades
- Hot IPOs
- Hot List
- Hot M&A
- Hot Mgmt Changes
- Hot New Coverage
- Hot Upgrades
- Insiders' Blog
- IPOs
- Life Enjoyed
- Litigation
- Management Comments
- Market Check
- Momentum Movers
- New Coverage
- Option EPS Action
- Options
- Press Releases
- Private Equity
- SEC Filings
- Special Dividends
- Special Reports
- Stock Splits
- Technicals
- Trader Talk
- Trading Halts
- Upgrades
GALECTIN (NQ:GALT)
Delayed:
4.00
+0.02 (0.50%)
Trade Now!
Previous Close
$3.98
52 Week High
$5.22
Open
$3.99
52 Week Low
$1.60
Day High
$4.05
P/E
N/A
Day Low
$3.95
EPS
$-0.77
Volume
15,365
ALERTS
|
RSS
All Recent
SI Reports
Press Releases
SEC Filings
Major News
Jun 12, 2013 08:31 AM
Form 8-K GALECTIN THERAPEUTICS For: Jun 12
Jun 12, 2013 08:00 AM
Tumor Immunotherapy Efficacy Increased in Both Breast and Prostate Cancer Preclinical Models with Addition of Galectin Inhibitor
Jun 4, 2013 06:00 PM
Form 4 GALECTIN THERAPEUTICS For: Jun 03 Filed by: MAULDIN JOHN F
May 30, 2013 05:04 PM
Form 8-K GALECTIN THERAPEUTICS For: May 23
May 30, 2013 11:19 AM
Form 4 GALECTIN THERAPEUTICS For: May 28 Filed by: FREEMAN KEVIN D
May 23, 2013 09:18 AM
Form 8-K GALECTIN THERAPEUTICS For: May 23
May 23, 2013 09:16 AM
Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders -- New Phone Number for Audio Portion of Presentation
May 15, 2013 08:43 AM
Form 8-K GALECTIN THERAPEUTICS For: May 15
May 15, 2013 08:02 AM
Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders
May 10, 2013 04:39 PM
Form 8-K GALECTIN THERAPEUTICS For: May 10
View All Articles
May 10, 2013 04:01 PM
Galectin (GALT) Posts Q1 Loss of 22c/Share
Nov 9, 2012 04:02 PM
Galectin (GALT) Posts Q3 Loss of 19c/Share
Aug 10, 2012 04:05 PM
Galectin (GALT) Reports Q2 Loss of $0.19
May 10, 2013 04:01 PM
Galectin (GALT) Posts Q1 Loss of 22c/Share
Apr 29, 2013 02:00 PM
Unusual 11 Mid-Day Movers 04/29: (OSH) (WRLS) (GALT) Higher; (LAS) (NTE) (GWAY) Lower
Apr 29, 2013 08:15 AM
Galectin (GALT) Issues Encouraging Update on anti-Galectin Drugs on Liver Cirrohsis
Feb 25, 2013 01:06 PM
Unusual 11 Mid-Day Movers 02/25: (ENMD) (GALT) (APPY) Higher; (AFFY) (CEDC) (DVAX) Lower
Jan 31, 2013 09:01 AM
Galectin (GALT) Submites IND for New GR-MD-02 Indication
Nov 26, 2012 09:16 AM
Galectin Therapeutics (GALT) Receives U.S. Patent NoA on Galectin Inhibitors in Liver Disease
Nov 9, 2012 04:02 PM
Galectin (GALT) Posts Q3 Loss of 19c/Share
Aug 10, 2012 04:05 PM
Galectin (GALT) Reports Q2 Loss of $0.19
Jul 25, 2012 01:51 PM
Unusual 11 Mid-Day Movers 07/25: (RVBD) (INVN) (LL) Higher; (RSH) (NFLX) (IGT) Lower
Jul 25, 2012 11:10 AM
Notable Analyst Rating Changes 07/25: (DOLE) (AMGN) (WHR) Upgraded; (AAPL) (TNK) (PM) Downgraded
View All Reports
Jun 12, 2013 08:00 AM
Tumor Immunotherapy Efficacy Increased in Both Breast and Prostate Cancer Preclinical Models with Addition of Galectin Inhibitor
May 23, 2013 09:16 AM
Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders -- New Phone Number for Audio Portion of Presentation
May 15, 2013 08:02 AM
Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders
May 10, 2013 04:00 PM
Galectin Therapeutics Reports First Quarter 2013 Financial Results
Apr 29, 2013 08:00 AM
Galectin Inhibitors Reverse Liver Cirrhosis in Preclinical Studies
View All Press Releases
Jun 12, 2013 08:31 AM
Form 8-K GALECTIN THERAPEUTICS For: Jun 12
Jun 4, 2013 06:00 PM
Form 4 GALECTIN THERAPEUTICS For: Jun 03 Filed by: MAULDIN JOHN F
May 30, 2013 05:04 PM
Form 8-K GALECTIN THERAPEUTICS For: May 23
May 30, 2013 11:19 AM
Form 4 GALECTIN THERAPEUTICS For: May 28 Filed by: FREEMAN KEVIN D
May 23, 2013 09:18 AM
Form 8-K GALECTIN THERAPEUTICS For: May 23
May 15, 2013 08:43 AM
Form 8-K GALECTIN THERAPEUTICS For: May 15
May 10, 2013 04:39 PM
Form 8-K GALECTIN THERAPEUTICS For: May 10
May 10, 2013 11:59 AM
Form 10-Q GALECTIN THERAPEUTICS For: Mar 31
May 1, 2013 05:03 PM
Form 4 GALECTIN THERAPEUTICS For: Apr 29 Filed by: Shlevin Harold H.
Apr 29, 2013 09:04 AM
Form 8-K GALECTIN THERAPEUTICS For: Apr 29
View All Filings
Entities mentioned with
GALT
Unusual 11 Mid-Day Movers
|
View Related Stories »
Earnings
|
View Related Stories »
Dividend
|
View Related Stories »
Carl Icahn
|
View Related Stories »
Citi
|
View Related Stories »
Bank of America
|
View Related Stories »
Piper Jaffray
|
View Related Stories »
JPMorgan
|
View Related Stories »
Credit Suisse
|
View Related Stories »
Raymond James
|
View Related Stories »
Merrill Lynch
|
View Related Stories »
RBC Capital
|
View Related Stories »
Notable Analyst Rating Changes
|
View Related Stories »
Credit Agricole
|
View Related Stories »
13D
|
View Related Stories »
Canaccord Genuity
|
View Related Stories »
Davenport
|
View Related Stories »
Needham & Company
|
View Related Stories »
Show More...
View All Entities